MetaStat, Inc. announced that Bruce R. Zetter, PhD has joined the company's Scientific and Clinical Advisory Board. Dr. Zetter is the Charles Nowiszewski Professor in the Departments of Cell Biology and Surgery at Harvard Medical School. Dr. Zetter conducts research at Children's Hospital, Boston where he has served as Vice President of Research and Chief Scientific Officer and is on the faculty of Harvard Medical School since 1978.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 587 | |
+48.54% | 5.69TCr | |
+37.15% | 3.97TCr | |
-6.02% | 3.93TCr | |
-6.90% | 2.87TCr | |
+12.97% | 2.62TCr | |
-16.91% | 1.98TCr | |
+31.71% | 1.23TCr | |
+28.18% | 1.22TCr | |
+0.38% | 1.21TCr |
- Stock Market
- Equities
- MTST Stock
- News MetaStat, Inc.
- MetaStat, Inc. Appoints Bruce R. Zetter, PhD to Scientific and Clinical Advisory Board